Sanigen Co. Ltd (KOSDAQ:188260)
1,993.00
-87.00 (-4.18%)
At close: Jan 30, 2026
Sanigen Co. Revenue
Sanigen Co. had revenue of 4.05B KRW in the quarter ending September 30, 2025, a decrease of -38.51%. This brings the company's revenue in the last twelve months to 27.30B, up 30.37% year-over-year. In the year 2024, Sanigen Co. had annual revenue of 24.01B with 7.82% growth.
Revenue (ttm)
27.30B
Revenue Growth
+30.37%
P/S Ratio
0.53
Revenue / Employee
n/a
Employees
n/a
Market Cap
14.41B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 24.01B | 1.74B | 7.82% |
| Dec 31, 2023 | 22.27B | -4.49B | -16.78% |
| Dec 31, 2022 | 26.76B | 1.54B | 6.09% |
| Dec 31, 2021 | 25.22B | 1.73B | 7.38% |
| Dec 31, 2020 | 23.49B | 3.23B | 15.92% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| DENTIS CO.,Ltd | 117.11B |
| Corentec | 106.14B |
| Alpha AI | 25.98B |
| Bio Protech | 20.58B |
| Finemedix | 10.48B |
| Genolution | 9.15B |
| Celemics | 6.13B |
| TASCOM | 5.53B |